Clinical and Translational Neuroscience最新文献

筛选
英文 中文
Imaging of nonatheromatous carotid artery disease 非动脉粥样硬化性颈动脉疾病的影像学检查
Clinical and Translational Neuroscience Pub Date : 2021-01-01 DOI: 10.1177/2514183X211014511
D. Montes, J. Romero
{"title":"Imaging of nonatheromatous carotid artery disease","authors":"D. Montes, J. Romero","doi":"10.1177/2514183X211014511","DOIUrl":"https://doi.org/10.1177/2514183X211014511","url":null,"abstract":"Imaging diagnosis of nonatheromatous carotid artery disease is challenging due to its low prevalence in contrast to that of atheromatous disease. Congenital anomalies are frequently discovered incidentally, as the chronicity of these conditions allows for compensatory flow development. The inflammatory conditions typically present with nonspecific courses, and a high clinical suspicion along with timely imaging evaluation can guide the diagnosis. Carotid dissection is the result of a partial disruption of the arterial wall and can be seen in previously healthy patients, in patients with underlying noninflammatory arteriopathies or trauma. Traumatic injuries to the carotid artery may occur under many different conditions and mechanisms and timely recognition of high-risk patients improves patient outcomes. Although free-floating thrombi (FFT) formation is typically seen with atherosclerotic plaque rupture, different conditions may also predispose to FFT. In this review article, we study the different imaging features of nonatheromatous carotid artery disease using ultrasonography, computed tomography angiography, magnetic resonance angiography, and digital subtraction angiogram.","PeriodicalId":242430,"journal":{"name":"Clinical and Translational Neuroscience","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130199383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Acute revascularization in ischemic stroke: Updated Swiss guidelines 缺血性卒中的急性血运重建:更新的瑞士指南
Clinical and Translational Neuroscience Pub Date : 2021-01-01 DOI: 10.1177/2514183X21999228
P. Michel, M. Diepers, P. Mordasini, Tilman Schubert, D. Bervini, J.-D. Rouvé, Y. Gasche, G. Schwegler, C. Bonvin, K. Nedeltchev, E. Carrera, G. Kägi, C. Cereda, T. Nyffeler, S. Wetzel, S. Wegener, H. Gensicke, S. Engelter, M. Arnold
{"title":"Acute revascularization in ischemic stroke: Updated Swiss guidelines","authors":"P. Michel, M. Diepers, P. Mordasini, Tilman Schubert, D. Bervini, J.-D. Rouvé, Y. Gasche, G. Schwegler, C. Bonvin, K. Nedeltchev, E. Carrera, G. Kägi, C. Cereda, T. Nyffeler, S. Wetzel, S. Wegener, H. Gensicke, S. Engelter, M. Arnold","doi":"10.1177/2514183X21999228","DOIUrl":"https://doi.org/10.1177/2514183X21999228","url":null,"abstract":"In acute ischemic stroke, intravenous thrombolysis (IVT) and acute endovascular therapy (EVT) have been shown to reduce long-term disability in randomized trials. International guidelines are partially not up to date and may not address situations for which there is limited scientific evidence. The goals of the present guidelines are to summarize the current scientific data for acute revascularization treatments to make sure that all Swiss Centers apply a similar, evidence, or consensus-based treatment standard. A multidisciplinary working group of the Swiss Stroke Society (SSS) searched and reviewed the literature on new randomized controlled trials (RCTs), large case series, meta-analyses, and other guidelines since the previous recommendations in 2009 to elaborate the consensus guidelines. The new RCTs have confirmed the effectiveness of IVT in various populations up to 4.5 h and proven the benefit of acute EVT up to approximately 8 h. For patients with unknown onset (including wake-up stroke), IVT and EVT can be effective up to 24 h after last proof of good health if patients are selected with advanced neuroimaging. Multiple case series and meta-analyses allow narrowing down the indications and relative and absolute contraindications to optimize the benefit–risk ratio of acute revascularization.","PeriodicalId":242430,"journal":{"name":"Clinical and Translational Neuroscience","volume":"113 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133340474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Stroke and splenic infarct in a 17-year-old patient with COVID-associated hypercoagulable state and relative ADAMTS13 deficiency 17岁冠状病毒相关高凝状态和相对ADAMTS13缺乏症患者的脑卒中和脾梗死
Clinical and Translational Neuroscience Pub Date : 2021-01-01 DOI: 10.1177/2514183X211020157
M. Pistor, A. Hoffmann, Thomas Horvath, M. Oberholzer, M. Arnold, S. Pilgram-Pastor
{"title":"Stroke and splenic infarct in a 17-year-old patient with COVID-associated hypercoagulable state and relative ADAMTS13 deficiency","authors":"M. Pistor, A. Hoffmann, Thomas Horvath, M. Oberholzer, M. Arnold, S. Pilgram-Pastor","doi":"10.1177/2514183X211020157","DOIUrl":"https://doi.org/10.1177/2514183X211020157","url":null,"abstract":"In this case report, we present the case of a 17-year-old stroke patient suffering from coronavirus disease (COVID)-19. He was successfully treated with intravenous and endovascular treatment. After extensive work-up, a hypercoagulable state due to the COVID-19 infection was assumed as probable cause of stroke.","PeriodicalId":242430,"journal":{"name":"Clinical and Translational Neuroscience","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122395031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Carotid artery stenosis – Current evidence and treatment recommendations 颈动脉狭窄-目前的证据和治疗建议
Clinical and Translational Neuroscience Pub Date : 2021-01-01 DOI: 10.1177/2514183X211001654
Mandy D Müller, L. Bonati
{"title":"Carotid artery stenosis – Current evidence and treatment recommendations","authors":"Mandy D Müller, L. Bonati","doi":"10.1177/2514183X211001654","DOIUrl":"https://doi.org/10.1177/2514183X211001654","url":null,"abstract":"Background: Carotid artery stenosis is an important cause for stroke. Carotid endarterectomy (CEA) reduces the risk of stroke in patients with symptomatic carotid stenosis and to some extent in patients with asymptomatic carotid stenosis. More than 20 years ago, carotid artery stenting (CAS) emerged as an endovascular treatment alternative to CEA. Objective and Methods: This review summarises the available evidence from randomised clinical trials in patients with symptomatic as well as in patients with asymptomatic carotid stenosis. Results: CAS is associated with a higher risk of death or any stroke between randomisation and 30 days after treatment than CEA (odds ratio (OR) = 1.74, 95% CI 1.3 to 2.33, p < 0.0001). In a pre-defined subgroup analysis, the OR for stroke or death within 30 days after treatment was 1.11 (95% CI 0.74 to 1.64) in patients <70 years old and 2.23 (95% CI 1.61 to 3.08) in patients ≥70 years old, resulting in a significant interaction between patient age and treatment modality (interaction p = 0.007). The combination of death or any stroke up to 30 days after treatment or ipsilateral stroke during follow-up also favoured CEA (OR = 1.51, 95% CI 1.24 to 1.85, p < 0.0001). In asymptomatic patients, there is a non-significant increase in death or stroke occurring within 30 days of treatment with CAS compared to CEA (OR = 1.72, 95% CI 1.00 to 2.97, p = 0.05). The risk of peri-procedural death or stroke or ipsilateral stroke during follow-up did not differ significantly between treatments (OR = 1.27, 95% CI 0.87 to 1.84, p = 0.22). Discussion and Conclusion: In symptomatic patients, randomised evidence has consistently shown CAS to be associated with a higher risk of stroke or death within 30 days of treatment than CEA. This extra risk is mostly attributed to an increase in strokes occurring on the day of the procedure in patients ≥70 years. In asymptomatic patients, there may be a small increase in the risk of stroke or death within 30 days of treatment with CAS compared to CEA, but the currently available evidence is insufficient and further data from ongoing randomised trials are needed.","PeriodicalId":242430,"journal":{"name":"Clinical and Translational Neuroscience","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128120355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Abstract Book: Joint Annual Congress of the Swiss Headache Society and the Swiss Pain Society 摘要:瑞士头痛学会和瑞士疼痛学会联合年会
Clinical and Translational Neuroscience Pub Date : 2020-07-01 DOI: 10.1177/2514183X20973125
L. Sirucek, R. Price, W. Gandhi, M. Hoeppli, E. Fahey, A. Qu, S. Becker, P. Schweinhardt
{"title":"Abstract Book: Joint Annual Congress of the Swiss Headache Society and the Swiss Pain Society","authors":"L. Sirucek, R. Price, W. Gandhi, M. Hoeppli, E. Fahey, A. Qu, S. Becker, P. Schweinhardt","doi":"10.1177/2514183X20973125","DOIUrl":"https://doi.org/10.1177/2514183X20973125","url":null,"abstract":"Book: Joint Annual Congress of the Swiss Headache Society and the Swiss Pain Society","PeriodicalId":242430,"journal":{"name":"Clinical and Translational Neuroscience","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132458755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postacute administration of the GABAA α5 antagonist S44819 promotes recovery of peripheral limb fine motor skills after permanent distal middle cerebral artery occlusion in rats 急性后给予GABAA α5拮抗剂S44819促进永久性大脑中动脉远端闭塞大鼠外周肢体精细运动技能的恢复
Clinical and Translational Neuroscience Pub Date : 2020-07-01 DOI: 10.1177/2514183X20948306
M. Pace, M. Falappa, Patricia Machado, Laura Facchin, D. Hermann, C. Bassetti
{"title":"Postacute administration of the GABAA α5 antagonist S44819 promotes recovery of peripheral limb fine motor skills after permanent distal middle cerebral artery occlusion in rats","authors":"M. Pace, M. Falappa, Patricia Machado, Laura Facchin, D. Hermann, C. Bassetti","doi":"10.1177/2514183X20948306","DOIUrl":"https://doi.org/10.1177/2514183X20948306","url":null,"abstract":"Background: Ischemic stroke causes hypoexcitability in the peri-infarct motor neocortex that stems from increased tonic γ-amino-butyric acid (GABA) activity in neurons. This hypoexcitability, while neuroprotective in the acute phase, may impair neuroplasticity and functional recovery in the subacute phase of stroke. The purpose of this study is to investigate the effect of delayed and prolonged administration of S44819, which is a potent and competitive selective antagonist of GABAA receptors, on the skilled reaching function in a rodent model of stroke. Methods: Male Sprague–Dawley rats (n = 15) were subjected to permanent middle cerebral artery occlusion. Starting 3 days after stroke, a vehicle or S44819 (3 or 10 mg/kg, BID) was delivered orally twice a day for 28 days. All animals were euthanized 2 weeks later after the washout period. A single pellet reaching task (SPR) was performed before (baseline value) and after the ischemic surgery at several time points (3, 10, 17, 24, 31, 38, and 45 days) to assess the motor deficit. Infarct volume and body changes were also evaluated. Results: S44819, administered at 10 but not 3 mg/kg, significantly improves SPR results over the 45 days after the ischemic surgery. No effect was observed in the infarct size and in the body weight over time between the groups investigated. Conclusion: S44819 at 10 mg/kg significantly enhances motor recovery on a skilled reaching task after sensory-motor cortex lesion. Additionally, our study, in light of the results of the RESTORE BRAIN (Randomized Efficacy and Safety Trial of Oral GABAA α5 antagonist S44819 after Recent ischemic Event) trial, may help clinicians to design clinical studies and stratify variables and patients adequately.","PeriodicalId":242430,"journal":{"name":"Clinical and Translational Neuroscience","volume":"279 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116287486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reflection on career choices in clinical neurosciences 对临床神经科学职业选择的反思
Clinical and Translational Neuroscience Pub Date : 2020-07-01 DOI: 10.1177/2514183X20968367
A. Restellini, C. Piguet
{"title":"Reflection on career choices in clinical neurosciences","authors":"A. Restellini, C. Piguet","doi":"10.1177/2514183X20968367","DOIUrl":"https://doi.org/10.1177/2514183X20968367","url":null,"abstract":"Medical faculties are responsible for high-level training, not only on clinical skills but also on scientific research and medical advances. There is an evident need to promote academic careers to ensure the continuity and improvement of top-notch health care. Even if Switzerland is one of the countries with the highest medical density per inhabitant, the lack of interest for academic careers has increased, resulting in difficulties to form clinician-scientists and ensure succession. In this article, we reflect on the challenges and the potential solutions in the training of an academic career.","PeriodicalId":242430,"journal":{"name":"Clinical and Translational Neuroscience","volume":"113 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117249612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From first symptoms to diagnosis: Initial clinical presentation of primary brain tumors 从最初的症状到诊断:原发性脑肿瘤的初步临床表现
Clinical and Translational Neuroscience Pub Date : 2020-07-01 DOI: 10.1177/2514183X20968368
B. Alther, V. Mylius, M. Weller, A. Gantenbein
{"title":"From first symptoms to diagnosis: Initial clinical presentation of primary brain tumors","authors":"B. Alther, V. Mylius, M. Weller, A. Gantenbein","doi":"10.1177/2514183X20968368","DOIUrl":"https://doi.org/10.1177/2514183X20968368","url":null,"abstract":"Background: Despite modern imaging methods, a long symptom-to-diagnosis interval can be observed in patients with primary brain tumors. Objective: The study evaluated the initial and subsequent clinical presentation of patients with brain tumors in the context of time to diagnosis, localization, histology, and tumor grading. Methods: In this retrospective analysis of 85 consecutive patients with primary brain tumors, we assessed the presenting symptoms and signs. The analyses were based on entries from medical records at the Department of Neurology of Zurich University Hospital between 2005 and 2010. Results: A total of 54 men and 31 women with a mean age at diagnosis of 48 years were included. 60% of the patients present with a malignant tumor (World Health Organization grading III–IV), 24.7% with a benign tumor (I–II), and 15.3% were not classified. The interval between symptom onset and diagnosis varied from 1 day to 96 months (median: 39 days). High-grade tumors (III–IV) were diagnosed significantly earlier than low-grade tumors (II) after the first symptoms occurred (median: 26 vs. 138 days; z = −3.847, p < 0.001). Conclusions: Symptoms with a short symptom-to-diagnosis interval such as nausea/vomiting, seizures, as well as of personality change are assumed to contribute to a faster diagnosis in high-grade tumors. Visual disturbances and headaches, although occurring relatively seldom, did not contribute to a decrease in time to diagnosis and should therefore be considered for further diagnostic workup.","PeriodicalId":242430,"journal":{"name":"Clinical and Translational Neuroscience","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122527724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Diagnosis of epilepsy after first seizure. Introducing the SWISS FIRST study 首次发作后癫痫的诊断。介绍瑞士第一项研究
Clinical and Translational Neuroscience Pub Date : 2020-07-01 DOI: 10.1177/2514183X20939448
B. Jin, P. De Stefano, V. Petroulia, C. Rummel, C. Kiefer, M. Reyes, Kaspar Anton Schindler, P. van Mierlo, M. Seeck, R. Wiest
{"title":"Diagnosis of epilepsy after first seizure. Introducing the SWISS FIRST study","authors":"B. Jin, P. De Stefano, V. Petroulia, C. Rummel, C. Kiefer, M. Reyes, Kaspar Anton Schindler, P. van Mierlo, M. Seeck, R. Wiest","doi":"10.1177/2514183X20939448","DOIUrl":"https://doi.org/10.1177/2514183X20939448","url":null,"abstract":"Diagnosis of epilepsy after a first unprovoked seizure is possible according to the guidelines by the International League Against Epilepsy, if the risk recurrence of a second unprovoked seizure is exceeding 60%. However, this cutoff constitutes only a proxy depending on the patients’ history, magnetic resonance imaging (MRI), and electroencephalography (EEG) findings but nevertheless also from the treating neurologists’ individual experience. In a Switzerland-wide observational study, we aim to recruit patients that were admitted to the emergency department with the referral diagnosis of a first and unprovoked seizure. We make use of optimized MRI protocols to identify potential structural epileptogenic lesions, introduce new imaging-based markers of epileptogenecity, and use most recent postprocessing methods as automatic morphometry, spike map analysis, and functional connectivity. With these diagnostic tools, we aim to segregate patients that present with epileptic seizures versus mimicks and non-epileptic seizures and stratify for every finding in MRI and EEG its predictive value for a second unprovoked seizure. These findings shall support neurologists to calculate and not only estimate the seizure recurrence rate in future.","PeriodicalId":242430,"journal":{"name":"Clinical and Translational Neuroscience","volume":"2007 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129611181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Neuroplasticity in children and adolescents in response to treatment intervention: A systematic review of the literature 儿童和青少年的神经可塑性对治疗干预的反应:文献的系统回顾
Clinical and Translational Neuroscience Pub Date : 2020-07-01 DOI: 10.1177/2514183X20974231
L. Weyandt, Christine Clarkin, E. Holding, S. May, Marisa E. Marraccini, B. G. Gudmundsdottir, E. Shepard, Lauren Thompson
{"title":"Neuroplasticity in children and adolescents in response to treatment intervention: A systematic review of the literature","authors":"L. Weyandt, Christine Clarkin, E. Holding, S. May, Marisa E. Marraccini, B. G. Gudmundsdottir, E. Shepard, Lauren Thompson","doi":"10.1177/2514183X20974231","DOIUrl":"https://doi.org/10.1177/2514183X20974231","url":null,"abstract":"The purpose of the present study was to conduct a systematic review of the literature, adhering to PRISMA guidelines, regarding evidence of neuroplasticity in children and adolescents in response to cognitive or sensory-motor interventions. Twenty-eight studies employing seven different types of neuroimaging techniques were included in the review. Findings revealed that significant variability existed across the 28 studies with regard to the clinical populations examined, type of interventions employed, neuroimaging methods, and the type of neuroimaging data included in the studies. Overall, results supported that experience-dependent interventions were associated with neuroplastic changes among children and adolescents in both neurotypical and clinical populations. However, it remains unclear whether these molecular neuroplastic changes, including the degree and direction of those differences, were the direct result of the intervention. Although the findings are encouraging, methodological limitations of the studies limit clinical utility of the results. Future studies are warranted that rigorously define the construct of neuroplasticity, establish consistent protocols across measurement techniques, and have adequate statistical power. Lastly, studies are needed to identify the functional and structural neuroplastic mechanisms that correspond with changes in cognition and behavior in child and adolescent samples.","PeriodicalId":242430,"journal":{"name":"Clinical and Translational Neuroscience","volume":"25 11","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121005531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信